Compositions and methods are provided for reducing, inhibiting, or preventing corrosion of a surface, the polyamine compounds corresponding to the structure of Formula 1 or 2, or a salt thereof:

##STR(1)##

wherein X.sub.1 is —C(O)R.sub.9 or —[C(R.sub.10R.sub.11)].sub.p—C(R.sub.12)(X.sub.2)—R.sub.13; X.sub.2 is —OH or —NH.sub.2; R.sub.1 and R.sub.4 are independently hydrogen, alkyl, or —[C(R.sub.10R.sub.11)].sub.p—C(R.sub.12)(X.sub.2)—R.sub.13; R.sub.2, R.sub.3, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.10, R.sub.11, and R.sub.12 are independently hydrogen or alkyl; R.sub.9 and R.sub.13 are independently C.sub.7 to C.sub.30 alkyl or alkenyl; m and o are integers from 1 to 10; n is an integer from 1 to 6; and p is an integer from 1 to 10;

##STR(2)##

wherein X.sub.2 is —OH or —NH.sub.2; R.sub.21, R.sub.22, R.sub.23, R.sub.24, R.sub.25, R.sub.26, and R.sub.28 are independently hydrogen or alkyl; R.sub.27 is C.sub.10 to C.sub.30 alkyl or alkenyl; m and o are integers from 1 to 10; n is an integer from 1 to 6; and q is an integer from 0 to 10.

Compositions and methods are provided for reducing, inhibiting, or preventing corrosion of a surface, the polyamine compounds corresponding to the structure of Formula 1 or 2, or a salt thereof:

##STR(1)##

wherein X.sub.1 is —C(O)R.sub.9 or —[C(R.sub.10R.sub.11)].sub.p—C(R.sub.12)(X.sub.2)—R.sub.13; X.sub.2 is —OH or —NH.sub.2; R.sub.1 and R.sub.4 are independently hydrogen, alkyl, or —[C(R.sub.10R.sub.11)].sub.p—C(R.sub.12)(X.sub.2)—R.sub.13; R.sub.2, R.sub.3, R.sub.5, R.sub.6, R.sub.7, R.sub.8, R.sub.10, R.sub.11, and R.sub.12 are independently hydrogen or alkyl; R.sub.9 and R.sub.13 are independently C.sub.7 to C.sub.30 alkyl or alkenyl; m and o are integers from 1 to 10; n is an integer from 1 to 6; and p is an integer from 1 to 10;

##STR(2)##

wherein X.sub.2 is —OH or —NH.sub.2; R.sub.21, R.sub.22, R.sub.23, R.sub.24, R.sub.25, R.sub.26, and R.sub.28 are independently hydrogen or alkyl; R.sub.27 is C.sub.10 to C.sub.30 alkyl or alkenyl; m and o are integers from 1 to 10; n is an integer from 1 to 6; and q is an integer from 0 to 10.

New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.

New cationic lipids are provided that are useful for delivering macromolecules, such as nucleic acids, into eukaryotic cells. The lipids can be used alone, in combination with other lipids and/or in combination with other transfection enhancing reagents to prepare transfection complexes.

The present disclosure relates to compounds of formulas (A) and (I), pharmaceutically acceptable salts thereof, and solvates of any of the foregoing, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer, such as colorectal cancer, using the same.

##STR00001##

The present disclosure relates to compounds of formulas (A) and (I), pharmaceutically acceptable salts thereof, and solvates of any of the foregoing, pharmaceutical compositions comprising the same, methods of preparing the same, intermediate compounds useful for preparing the same, and methods for treating or prophylaxis of diseases, in particular cancer, such as colorectal cancer, using the same.

##STR00001##

The disclosure features novel lipids and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

The disclosure features novel lipids and compositions involving the same. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) include a novel lipid as well as additional lipids such as phospholipids, structural lipids, and PEG lipids. Lipid nanoparticles (e.g., empty LNPs or loaded LNPs) further including therapeutic and/or prophylactics such as RNA are useful in the delivery of therapeutic and/or prophylactics to mammalian cells or organs to, for example, regulate polypeptide, protein, or gene expression.

The present disclosure relates to a compound of Formula (I)

##STR00001##

or a pharmaceutically acceptable salt thereof, which can be incorporated into a lipid particle for delivering an active agent, such as a nucleic acid.

Methods for providing corrosion inhibition in conduits, containers, and wellbores penetrating subterranean formations are provided. In some embodiments, the methods comprise contacting a metal surface with a fluid comprising a corrosion inhibitor additive. In certain embodiments, the corrosion inhibitor additive comprises a compound comprising a hydrophobic cation moiety, one or more lipophilic tails, and a linking moiety.